LONDON—Hematopoietic stem cells are not displaced and depleted by malignant cells in patients with acute myeloid leukaemia but merely put to sleep, according to research from London published in PNAS Early Edition. Professor John Gribben from Barts Cancer Institute in London discusses their finding and explains how this gives new opportunities for treating AML.
You may also like...
ASCO Audio Journal of Oncology in Advance – July 15th, 2007 – reporting from: ASCO Annual Meeting, Chicago, June 1-5, 2007 15 Jul, 2007 Brachytherapy Improves Survival for Inoperable Early-Stage Endometrial Cancer 28 Apr, 2015 Reassurance on Ductal Carcinoma in Situ (DCIS) Treatment De-Escalation 17 Apr, 2018 Cetuximab better than bevacizumab first-line in KRAS wild type expressing colorectal tumours 21 Jun, 2013
- Previous story Chimeric antigen receptor T-cell therapy rescues kids with relapsing acute lymphoblastic leukaemia
- Next story Normal stem cells are not depleted in acute myeloid leukaemia and could be targeted therapeutically
- Ultrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
- First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
- Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
- Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
- MMR vaccine’s non-specific effects: adherence to recommended vaccination schedules protects children against non-vaccination-specific infections tooFebruary 28, 2014